# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Exane BNP Paribas analyst Kevin Grundy initiates coverage on Colgate-Palmolive (NYSE:CL) with a Outperform rating and announ...
Consumer outlook remains strong with higher wages and disposable income predicted, boosting spending. Goldman Sachs recommends ...
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target fr...
Michael Burry, famous for predicting 2008 crisis, made headlines with his latest 13F filing. He shifted towards commodities &am...
Argus Research analyst Chris Graja maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $97 to ...
Cannabis producer Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) announced on Wednesday its financial and operating resul...
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahas...